Table 3.

Subgroup of those patients who initially had either a high post-void residual (> 250 ml, > 50% of their bladder capacity or an indwelling catheter) and/or a prostate volume > 60 ml

	Baseline	1 month	6 months	12 months	24 months
IPSS
N	33	24	23	23	22
Mean ± SD	19.83 ± 6.38	9.58 ± 6.13	9.6 ± 3.33	9.82 ± 1.66	11.17 ± 3.59
95% CI	17.14–22.53	5.69–13.48	7.75–11.45	8.70–10.94	8.89–13.45
p value	–	< 0.0001	< 0.0001	< 0.0001	0.0004
QoL
N	33	25	23	17	25
Mean ± SD	3.79 ± 1.35	1.82 ± 0.98	2.00 ± 0.96	2.00 ± 0.85	1.93 ± 0.83
95% CI	3.22–4.36	1.16–2.48	1.45–2.55	1.46–2.54	1.45–2.41
p value	–	0.0003	< 0.0001	0.0002	0.0004
PVR (ml)
N	31	19	20	15	21
Mean ± SD	333.71 ± 429.59	202.75 ± 419.77	74.62 ± 92.95	75.11 ± 57.71	63.33 ± 54.66
95% CI	138.17–29.26	63.96–469.46	18.45–30.78	30.75–119.47	28.60–98.06
p value	–	0.0149	0.0009	0.0377	0.0174
Qmax (ml/s)
N	32	12	15	10	14
Mean ± SD	9.53 ± 2.61	14.51 ± 6.11	14.23 ± 3.61	12.45 ± 3.50	13.42 ± 2.97
95% CI	8.41–10.66	10.62–18.39	12.23–6.23	9.95–14.95	11.70–15.14
p value	–	0.0004	0.0003	0.0438	0.0031